Filter
106
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
13
New Publications
31
Language
Document type
No document type
52
Guidelines
22
Studies & Reports
11
Manuals
10
Strategic & Response Plan
5
Fact sheets
3
Training Material
1
Situation Updates
1
Infographics
1
Countries / Regions
South Africa
6
Western and Central Europe
6
India
5
Kenya
5
Eastern Europe
5
Uganda
4
Rwanda
4
Nigeria
3
Malawi
3
Global
3
Congo, Democratic Republic of
2
Ghana
2
Nepal
2
Bangladesh
2
Sudan
2
Latin America and the Carribbean
2
Russia
2
Sierra Leone
1
Liberia
1
Senegal
1
Ethiopia
1
Cameroon
1
Zimbabwe
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Tanzania
1
Namibia
1
Botswana
1
Madagascar
1
Sri Lanka
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Asia
1
Africa
1
Bhutan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
46
Clinical Guidelines
17
Public Health
3
Women & Child Health
2
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
TB
19
AMR
13
Pharmacy
13
HIV
7
COVID-19
7
NTDs
5
Malaria
3
Refugee
1
Global Health Education
1
Caregiver
1
NCDs
1
This updated glossary for malaria aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for malaria programmes, and policy-makers in malaria-ende
...
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t
...
Documentation of Best Practices and Bottlenecks to Program Implementation in Senegal
SUMMARY REPORT
Accessed at March 2014
NEMLIST | Sixth Edition | February 2016
Towards universal access
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
14–22 April 2015
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect
...
17–24 November 2015
Master of Science in Pharmaceutical Management Dissertation
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a
...
